The U.S. Multiplex Assays Market is projected to grow from USD 1.12 Billion in 2025 to USD 2.65 Billion by 2035, while Europe ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

Dr. Lamas, a contributing Opinion writer, is a pulmonary and critical care physician at Brigham and Women’s Hospital in Boston. See more of our coverage in your search results.Encuentra más de nuestra ...

Black kidney donors with the high-risk APOL1 genotype are about twice as likely to develop reduced kidney function as those without it. Medical algorithms consider all Black kidney donor candidates as ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

When standard treatment failed, genetics revealed the answerA personal health journey has sparked a conversation around the role of genetics in preventive healthcare. After standard treatment failed ...

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

A six-year-old boy from Sussex has become one of only about 75 people worldwide to be diagnosed with an ultra-rare genetic ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD ...

The U.S. Life Science Tools Market is projected to grow from USD 68.50 Billion in 2025 to USD 189.48 Billion by 2035, while ...